65 i b, drugs, pharmaceuticals, & hematology related products, FSS contract award

Active Awarded Last action

Contract number
36F79724D0038
Awardee
Awarding agency
Task orders
0

Award facts

Opportunity
  • 65IB Solicitation number
Last date to order 56% complete
IDV ceiling
$225,000.00
Award type
Multiple award
Who can order
All agencies
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Fixed Price with Economic Price Adjustment

Award details come from SAM.gov/FPDS.

About this IDV

Acer Therapeutics Inc. (UEI: C6EKP8VELDC1) was awarded a multiple-award Federal Supply Schedule contract by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency within the Department of Veterans Affairs, effective January 1, 2024, through December 31, 2028. This contract, established under the Pharmaceuticals and Drugs (FSS-61-IB) master schedule, carries a ceiling value of $225,000 and requires no set-aside provisions. The contract covers the supply of drugs, pharmaceuticals, and hematology-related products to support the medical needs of the Veterans Health Administration network. No original solicitation documentation was provided; however, the contract represents a continuation of Acer's pharmaceutical supply relationship with VISN 12, following a previous $25,000 interim agreement that concluded on December 31, 2023.

Acer Therapeutics specializes in the development and distribution of specialized pharmaceutical products, with particular expertise in hematology medications. The company's primary product offerings under federal contracts include MIPLYFFA and OLPRUVA, specialized pharmaceuticals supplied through complementary contracting mechanisms. Most notably, Acer secured a single-award Blanket Purchase Agreement through the National Acquisition Center on July 8, 2025, for MIPLYFFA and OLPRUVA with a substantially larger ceiling value of $1,891,583.25, performance through July 7, 2026, and incorporation of 2026 Public Law pricing updates. This tiered contracting approach—combining the VISN 12 FSS contract with the National Acquisition Center BPA—enables federal healthcare entities to access these specialized medications through pre-negotiated pricing and established terms without requiring repetitive competitive solicitations, while maintaining cost controls through defined contract ceilings.

IDV awards

IDV Agency Ceiling Awarded
36E79725A0022 BPA for miplyffa and olpruva National Acquisition Center (VA) $1,891,583

Transactions

Action Obligated Date
Vendor Address Change P00006 · Administrative change- address change, signatory authority form, and point of contact $0
Supplemental Agreement for work within scope P00005 · 2026 public law pricing updates $0
Supplemental Agreement for work within scope P00004 · 42-a product addition permanent FCP single pricing $0
Supplemental Agreement for work within scope P00003 · Public law 2025 $0
Other Administrative Action P00002 · Admin change SAF and POC update $0
Supplemental Agreement for work within scope P00001 · 42-a public law permanent lifecycle single pricing $0
Original award $0

Quick answers

Who was awarded contract 36F79724D0038?

36F79724D0038 was awarded to Acer Therapeutics Inc. by Veterans Integrated Service Network 12 (Veterans Health Administration) on January 1, 2024.

How much is contract 36F79724D0038 worth?

36F79724D0038's own ceiling is $225,000.

Who can order from contract 36F79724D0038?

36F79724D0038 is a multiple award federal supply schedule. All agencies can place orders on it.

Is contract 36F79724D0038 part of a contract vehicle?

Yes. 36F79724D0038 is part of Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36F79724D0038 competed?

The extent of competition for 36F79724D0038 was full and open competition.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV